Eppley Institute for Cancer Research

Fingerprint Dive into the research topics where Eppley Institute for Cancer Research is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Neoplasms Medicine & Life Sciences
DNA Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Proteins Medicine & Life Sciences
Cells Chemical Compounds
Breast Neoplasms Medicine & Life Sciences
Butyrylcholinesterase Medicine & Life Sciences
Genes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Sophie Alvarez
No photo of James Olen Armitage

James Olen Armitage, MD

Person: Member, Academic, Clinician

19752019

Projects 1975 2021

Quinoxalines
Mutation
Adenocarcinoma
Adenosine Triphosphate
Neoplasms
Genomics
Oligonucleotide Array Sequence Analysis
DNA Sequence Analysis
Research Personnel
Macromolecules

Research Output 1967 2020

A phase I study of weekly doxorubicin and oral topotecan for patients with relapsed or refractory small cell lung cancer (SCLC): A Fred and Pamela Buffet Cancer Center Clinical Trials Network study

Ernani, V., Jahan, R., Smith, L. M., Marr, A. S., Kimbrough, S. E., Kos, M. E., Tijerina, J., Pivovar, S., Lakshmanan, I., Ketcham, M., Rauth, S., Mallya, K., Nasser, M. W., Jain, M., Kessinger, A., Batra, S. K. & Ganti, A. K., 2020, In : Cancer Treatment and Research Communications. 22, 100162.

Research output: Contribution to journalArticle

Open Access
Topotecan
Small Cell Lung Carcinoma
Doxorubicin
Clinical Trials
Neoplasms
4 Citations (Scopus)

Aberrations in DNA repair pathways in cancer and therapeutic significances

Motegi, A., Masutani, M., Yoshioka, K. I. & Bessho, T., Oct 2019, In : Seminars in Cancer Biology. 58, p. 29-46 18 p.

Research output: Contribution to journalReview article

DNA Repair
Genomic Instability
Neoplasms
Physiological Phenomena
Therapeutics

Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells

Vengoji, R., Macha, M. A., Nimmakayala, R. K., Rachagani, S., Siddiqui, J. A., Mallya, K., Gorantla, S., Jain, M., Ponnusamy, M. P., Batra, S. K. & Shonka, N., Jun 18 2019, In : Journal of Experimental and Clinical Cancer Research. 38, 1, 266.

Research output: Contribution to journalArticle

Open Access
temozolomide
Glioblastoma
Carcinogenesis
Neoplastic Stem Cells
Epidermal Growth Factor Receptor